Non-Inferiority Trials

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2011年 / 53卷 / 1355期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [31] Comments on 'Current issues in non-inferiority trials'
    Koch, Gary G.
    STATISTICS IN MEDICINE, 2008, 27 (03) : 333 - 342
  • [32] Non-inferiority design for trials in multiple sclerosis
    Sormani, Maria Pia
    Wiendl, Heinz
    LANCET NEUROLOGY, 2024, 23 (10): : 970 - 970
  • [33] ¿Clinical trials of superiority, non-inferiority or equivalence?
    Manterola, Carlos
    Hernandez-Leal, Maria Jose
    Otzen, Tamara
    Holguin, Juan Pablo
    Salgado, Carla
    Grande, Luis
    REVISTA CHILENA DE INFECTOLOGIA, 2024, 41 (01): : 157 - 164
  • [34] Non-inferiority trials: the 'at least as good as' criterion
    Laster, LL
    Johnson, MF
    STATISTICS IN MEDICINE, 2003, 22 (02) : 187 - 200
  • [35] An evidential approach to non-inferiority clinical trials
    Wang, Sue-Jane
    Blume, Jeffrey D.
    PHARMACEUTICAL STATISTICS, 2011, 10 (05) : 440 - 447
  • [36] Strength of evidence of non-inferiority trials-The adjustment of the type I error rate in non-inferiority trials with the synthesis method
    Kang, Seung-Ho
    Tsong, Yi
    STATISTICS IN MEDICINE, 2010, 29 (14) : 1477 - 1487
  • [37] Two-stage winner designs for non-inferiority trials with pre-specified non-inferiority margin
    Wang, Pin-Wen
    Lu, Shou-En
    Lin, Yong
    Shih, Weichung J.
    Lan, K. K. Gordon
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2017, 183 : 44 - 61
  • [38] Non-adherence in non-inferiority trials: pitfalls and recommendations
    Mo, Yin
    Lim, Cherry
    Watson, James A.
    White, Nicholas J.
    Cooper, Ben S.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [39] Emergent HIV Brug resistance in non-inferiority trials
    Ripamonti, Diego
    Zazzi, Maurizio
    LANCET HIV, 2023, 10 (10): : E632 - E634
  • [40] A comparison of testing methods in non-inferiority clinical trials
    Park, Jieun
    Lee, Jae Won
    COMMUNICATIONS FOR STATISTICAL APPLICATIONS AND METHODS, 2024, 31 (06)
12345